Tamar BenYedidia - BiondVax Pharmaceuticals Chief Scientific Officer
Executive
Dr. Tamar BenYididia serves as Chief Scientific Officer at Biondvax Pharmaceuticals Ltd since 2004. Her work experience includes the following roles Lab Manager at Biotechnology General Ltd and Research Associate at Weizmann Institute of ScienceDepartment of Immunology . Dr. BenYedidia was involved in two European Consortium projects related to the evaluation of different approaches for vaccination, was invited to address conferences worldwide since 2004.
| Age | 59 |
| Tenure | 21 years |
| Phone | 972 8 930 2529 |
| Web | https://www.biondvax.com |
BiondVax Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (0.3089) % which means that it has lost $0.3089 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (56.0153) %, meaning that it created substantial loss on money invested by shareholders. BiondVax Pharmaceuticals' management efficiency ratios could be used to measure how well BiondVax Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.BiondVax Pharmaceuticals currently holds 21.54 M in liabilities. BiondVax Pharmaceuticals has a current ratio of 1.68, which is within standard range for the sector. Note, when we think about BiondVax Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Ety MBA | Mediwound | 63 | |
| Mark Conley | SAB Biotherapeutics | N/A | |
| Hayley Parker | PepGen | N/A | |
| Barry Wolfenson | Mediwound | 58 | |
| Andrew Taubman | Adial Pharmaceuticals | N/A | |
| Esther Jhun | Surrozen | N/A | |
| Carlos Carillo | SAB Biotherapeutics | N/A | |
| David MD | Mineralys Therapeutics, Common | 70 | |
| Sari Fishman | Can Fite Biopharma | 53 | |
| Jennifer Huber | AN2 Therapeutics | N/A | |
| Thomas OBrien | GeoVax Labs | N/A | |
| Renate Gloggner | Molecular Partners AG | 55 | |
| MPH MD | Salarius Pharmaceuticals | N/A | |
| Daniel Steiner | Molecular Partners AG | N/A | |
| MD MBA | SAB Biotherapeutics | 53 | |
| Alan Freidman | Transcode Therapeutics | N/A | |
| Adam Esq | BioLineRx | N/A | |
| RN MBA | Transcode Therapeutics | N/A | |
| MS MD | Armata Pharmaceuticals | 50 | |
| Joshua JD | AN2 Therapeutics | 47 | |
| Calais Pharm | Transcode Therapeutics | 65 | |
Management Performance
| Return On Equity | -56.02 | |||
| Return On Asset | -0.31 |
BiondVax Pharmaceuticals Leadership Team
Elected by the shareholders, the BiondVax Pharmaceuticals' board of directors comprises two types of representatives: BiondVax Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BiondVax. The board's role is to monitor BiondVax Pharmaceuticals' management team and ensure that shareholders' interests are well served. BiondVax Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BiondVax Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, Chief Officer | ||
| BSc Eng, Chief Officer | ||
| Tamar BenYedidia, Chief Scientific Officer | ||
| Dalit Fischer, Head RD | ||
| MSc MBA, CEO Director | ||
| Moran LLB, Chief Staff |
BiondVax Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BiondVax Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -56.02 | |||
| Return On Asset | -0.31 | |||
| Current Valuation | 21.94 M | |||
| Shares Outstanding | 3.65 M | |||
| Shares Owned By Insiders | 20.01 % | |||
| Shares Owned By Institutions | 10.69 % | |||
| Number Of Shares Shorted | 4.88 K | |||
| Price To Earning | (4.91) X | |||
| Price To Book | 7.48 X | |||
| EBITDA | (10.5 M) |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in BiondVax Stock
If you are still planning to invest in BiondVax Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BiondVax Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |